Clinical Study of LBBP
Launched by SECOND AFFILIATED HOSPITAL, SCHOOL OF MEDICINE, ZHEJIANG UNIVERSITY · Jun 8, 2021
Trial Information
Current as of July 01, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how different ways of pacing the heart can help patients with slow heart rates (bradyarrhythmias) and heart failure. The goal is to compare the short-term and long-term effects and safety of various pacing locations in the heart, like the right atrium, right ventricle, and left bundle branch. By understanding which pacing method works best, the researchers hope to improve treatment for these conditions.
To participate in the study, you need to be between the ages of 65 and 74 or 36 and 52 years old and have received a pacemaker at the Second Hospital of Zhejiang Medical University. It’s important that you can understand the study and work with the researchers. If you join, you can expect regular follow-ups to monitor how well the pacing is working for you and to ensure your safety throughout the trial.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients who received pacemaker implantation in the Second Hospital of Zhejiang Medical University by Pan Xiaohong and other surgeons.
- • Patients who have the ability to understand the test and can cooperate with investigators.
- Exclusion Criteria:
- • Patients who unable to understand or unwilling to fill in informed consent forms or follow visitors
About Second Affiliated Hospital, School Of Medicine, Zhejiang University
The Second Affiliated Hospital of Zhejiang University School of Medicine is a leading clinical research institution dedicated to advancing healthcare through innovative medical practices and rigorous scientific inquiry. With a robust infrastructure and a multidisciplinary team of experienced researchers and clinicians, the hospital is committed to conducting high-quality clinical trials that address critical health challenges. As an integral part of Zhejiang University, the hospital leverages academic expertise and cutting-edge technology to foster collaboration in research, education, and patient care, ultimately aiming to improve patient outcomes and contribute to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hangzhou, Zhejiang, China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials